Many patients see great results
you still have plenty of the previous dose in your system, and adding a new dose slightly early doesnt double the amount immediately
Semaglutide mimics the GLP-1 hormone that naturally occurs in your body
The glucagon receptor activation in retatrutide may actually support preferential fat oxidation
Routine medical review is advisable if: Light-headedness occurs frequently or predictably (e.g., after each injection) Symptoms develop after a dose increase and do not improve within one to two weeks You experience recurrent episodes of low blood glucose readings Light-headedness is associated with persistent nausea, vomiting, or diarrhoea You have concerns about medication interactions or other health conditions Your healthcare professional may need to adjust your Ozempic dose, review concomitant medications (particularly other diabetes treatments, antihypertensives, or diuretics), or investigate alternative causes
Retatrutide is a triple agonist acting on the GIP, GLP-1 and glucagon receptors